CT angiography to evaluate coronary artery disease and revascularization requirement before trans-catheter aortic

Alexia Rossi1, Carlo N De Cecco2, Simon R O Kennon1

  • 1NIHR Cardiovascular Biomedical Research Unit at Barts, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London & Department of Cardiology, Barts Health NHS Trust, London, UK.

Insights

Coronary computed tomography angiography (CTA) is questionable for ruling out coronary artery disease (CAD) in transcatheter aortic valve replacement (TAVR) candidates with severe calcifications. However, CTA may be useful in TAVR candidates with less severe coronary calcifications.

Area of Science:

  • Cardiology
  • Radiology
  • Medical Imaging

Background:

  • Coronary artery disease (CAD) and aortic stenosis share risk factors and pathophysiology.
  • Transcatheter aortic valve replacement (TAVR) is a treatment for severe aortic stenosis.
  • Evaluating CAD in TAVR candidates is crucial for optimal outcomes.

Purpose of the Study:

  • To assess the clinical utility of coronary computed tomography angiography (CTA) in identifying CAD.
  • To determine if CTA can predict the need for revascularization in severe aortic stenosis patients undergoing TAVR.
  • To evaluate CTA's diagnostic performance across different coronary calcification levels.

Main Methods:

  • 140 patients without known CAD undergoing TAVR evaluation were included.
  • Calcium scoring and CTA were performed, with invasive coronary angiography (ICA) as the reference standard.
  • CAD was defined by ≥50% and ≥70% diameter reduction thresholds; revascularization prediction used ≥70% stenosis and high-risk CAD findings.

Main Results:

  • 41% of patients had CAD by the 50% threshold and 16% by the 70% threshold on ICA.
  • CTA and ICA showed similar predictive values for revascularization (OR 3.22 vs. 4.62).
  • CTA's diagnostic performance was superior in patients with low Agatston calcium scores (<400) compared to high scores (AUC 0.81 vs. 0.63).

Conclusions:

  • CTA is questionable for excluding CAD in TAVR candidates with severe coronary calcifications.
  • CTA may have a clinical role in TAVR candidates with less severe coronary calcifications (30% of this cohort).
  • Further research is needed to define CTA's precise role in TAVR patient selection.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
434
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.8K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
518
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
338
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
343
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
680